Medical expenditures for children with an autism spectrum disorder in a privately insured population

Journal of Autism and Developmental Disorders

Volumn 38, Issue 3, 2008, Pages 546-552

  Shimabukuro, Tom T ^a   Grosse, Scott D ^b   Rice, Catherine ^b  

^a NATIONAL CENTER FOR IMMUNIZATION AND RESPIRATORY DISEASES   (United States)

^b NATIONAL CENTER ON BIRTH DEFECTS AND DEVELOPMENTAL DISABILITIES   (United States)

Author keywords

Autism; Autism spectrum disorders; Cost ratio; Incremental cost; Medical expenditures

Indexed keywords

ADOLESCENT; ADULT; ARTICLE; AUTISM; CHILD; CONTROLLED STUDY; COST BENEFIT ANALYSIS; DATA BASE; EMPLOYER; FEMALE; GROUPS BY AGE; HEALTH CARE COST; HEALTH CARE UTILIZATION; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PRIVATE HEALTH INSURANCE; REIMBURSEMENT; SEX RATIO;

ADOLESCENT; ADULT; AUTISTIC DISORDER; CHILD; CHILD, PRESCHOOL; FEMALE; HEALTH EXPENDITURES; HUMANS; INFANT; INSURANCE, HEALTH; MALE; PRIVATE SECTOR;

EID: 40049088277     PISSN: 01623257     EISSN: 15733432     Source Type: Journal    
DOI: 10.1007/s10803-007-0424-y     Document Type: Article

References (19)

1. Aman, M. G., Lam, K. S., & Collier-Crespin, A. (2003). Prevalence and patterns of use of psychoactive medicines among individuals with autism in the Autism Society of Ohio. Journal of Autism and Developmental Disorders, 33, 527-534.
2. Centers for Disease Control, Prevention. (2006). Mental health in the United States: Parental report of diagnosed autism in children aged 4-17 years-United States, 2003-2004. Morbidity and Morality Weekly Report, 55, 481-486.
3. Croen, L. A., Najjar, D. V., Ray, G. T., Lotspeich, L., & Bernal, P. (2006). A comparison of health care utilization and costs of children with and without autism spectrum disorders in a large group-model health plan. Pediatrics, 118, e1203-e1211.
4. Ganz, M. L. (2006). The costs of autism. In S. O. Moldin, & J. L. R. Rubenstein (Eds.), Understanding autism: From basic neuroscience to treatment, 1st edn. (pp. 475-502). Boca Raton, FL: CRC Press.
5. Gurney, J. G., McPheeters, M. L., & Davis, M. M. (2006). Parental report of health conditions and health care use among children with and without autism: National Survey of Children's Health. Archives of Pediatrics & Adolescent Medicine, 160, 825-830.
6. Jarbrink, K., & Knapp, M. (2001). The economic impact of autism in Britain. Autism, 5, 7-22.
7. Langworthy-Lam, K. S., Aman, M. G., & Van Bourgondien, M. E. (2002). Prevalence and patterns of use of psychoactive medicines in individuals with autism in the Autism Society of North Carolina. Journal of Child and Adolescent Psychopharmacology, 12, 311-321.
8. Liptak, G. S., Stuart, T., & Auinger, P. (2006). Health care utilization and expenditures for children with autism: Data from U.S. national samples. Journal of Autism and Developmental Disorders, 36, 871-879.
9. Mandell, D. S., Cao, J., Ittenbach, R., & Pinto-Martin, J. (2006). Medicaid expenditures for children with autistic spectrum disorders: 1994 to 1999. Journal of Autism and Developmental Disorders, 36, 475-485.
10. Martin, A., Scahill, L., Klin, A., & Volkmar, F.R. (1999). Higher-functioning pervasive developmental disorders: Rates and patterns of psychotropic drug use. Journal of the American Academy of Child & Adolescent Psychiatry, 38, 923-931.
11. Newschaffer, C. J., & Curran, L. K. (2003). Autism: An emerging public health problem. Public Health Reports, 118, 393-399.
12. Oswald, D. P., & Sonenklar, N. A. (2007). Medication use among children with autism spectrum disorders. Journal of Child and Adolescent Psychopharmacology, 17, 348-355.
13. Ouyang, L., Grosse S. D., Armour, B. S., & Waitzman, N. J. (2007). Health care expenditures of children and adults with spina bifida in a privately insured U.S. population. Birth Defects Research Part A: Clinical and Molecular Teratology, 79, 552-558.
14. Peele, P. B., Lave, J. R., & Kelleher, K.J. (2002). Exclusions and limitations in children's behavioral health care coverage. Psychiatric Services, 53, 591-594.
15. SAS Institute. (2004). SAS 9.1. Cary, NC: Author.
16. Thompson Medstat. (2003). MarketScan® research databases user guide and database dictionary. Ann Arbor, MI: Author.
17. Thompson Medstat. (2004). DataProbe® end user training. Ann Arbor, MI: Author.
18. Wiggins, L. D., Biao, J., & Rice, C. (2006). Examination of the time between first evaluation and first autism spectrum diagnosis in a population-based sample. Journal of Developmental & Behavioral Pediatrics, 27, S79-S87.
19. Yeargin-Allsopp, M., Rice, C., Karapurkar, T., Doernberg, N., Boyle, C., & Murphy, C. (2003). Prevalence of autism in a US metropolitan area. JAMA, 289, 49-55.